CMV pneumonitis
| CMV pneumonitis |
|
CMV pneumonitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
CMV pneumonitis On the Web |
|
American Roentgen Ray Society Images of CMV pneumonitis |
For the WikiPatient page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating CMV pneumonitis
Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
History and Symptoms
Laboratory Findings
Chest X Ray
Risk Stratification and Prognosis
Treatment
Future or Investigational Therapies
- Trials of ganciclovir with CMV IgG have not shown a consistent benefit in all studies.
- Foscarnet is an alternative agent but data on its efficacy is lacking